See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Using HER2DX and Imaging to Guide Early HER2-Positive Breast Cancer Treatment

Summary by MedPage Today
(MedPage Today) -- As the HER2DX assay gains traction in early-stage HER2-positive breast cancer, researchers are exploring whether it could be used to guide treatment with trastuzumab deruxtecan (T-DXd, Enhertu). Results from CompassHER2-pCR and...

3 Articles

MedPage TodayMedPage Today
Center

Using HER2DX and Imaging to Guide Early HER2-Positive Breast Cancer Treatment

(MedPage Today) -- As the HER2DX assay gains traction in early-stage HER2-positive breast cancer, researchers are exploring whether it could be used to guide treatment with trastuzumab deruxtecan (T-DXd, Enhertu). Results from CompassHER2-pCR and...

·New York, United States
Read Full Article
cancernetwork.comcancernetwork.com

Dissecting T-DXd/Dato-DXd Approvals in Breast Cancer

With the recent approvals of T-DXd and Dato-DXd, the care for breast cancer continues to evolve and expand.

Read Full Article
3cat.cat3cat.cat

A Test Predicts the Probability of Metastasis in Breast Cancer and Whether a Drug Is Contraindicated

It is an innovation that has already been incorporated by some hospitals and that comes from a Catalan research laboratory.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

3cat.cat broke the news in on Thursday, July 17, 2025.
Sources are mostly out of (0)

Similar News Topics

Breast Cancer icon

Breast Cancer

Innovation icon

Innovation

News
For You
SearchBlindspotLocal